PIMA541589

alpha Galactosidase Monoclonal Antibody (C8), Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIMA541589-Each-of-1 In Stock ₹ 44,989.50

PIMA541589 - Each of 1

₹ 44,989.50

In Stock

Quantity

1

Base Price: ₹ 44,989.50

GST (18%): ₹ 8,098.11

Total Price: ₹ 53,087.61

Antigen

alpha Galactosidase

Classification

Monoclonal

Concentration

1 mg/mL

Formulation

PBS with 50% glycerol and 0.05% ProClin 300

Gene Accession No.

P06280

Gene Symbols

GLA

Immunogen

Recombinant protein Galactosidase Alpha. The antigen corresponds to amino acid range 81-429 of the target protein.

Quantity

200 μL

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG2b κ

Applications

Immunohistochemistry (Paraffin), Western Blot

Clone

C8

Conjugate

Unconjugated

Gene

GLA

Gene Alias

Agalsidase; agalsidase alfa; Ags; Alpha-D-galactosidase A; alpha-D-galactoside galactohydrolase; alpha-D-galactoside galactohydrolase 1; alpha-gal A; alpha-galactosidase A; GALA; galactosidase alpha; galactosidase, alpha; GLA; Melibiase

Host Species

Mouse

Purification Method

Protein A/G

Regulatory Status

RUO

Gene ID (Entrez)

2717

Content And Storage

-20°C

Form

Liquid

Related Products

Img

Novus Biologicals

NB082228

--

Img

Novus Biologicals

NB082225

--

Img

Novus Biologicals

NB317031

--

Img

Thermo Scientific

PIPA5122227

--

Img

Thermo Scientific

PIMA531618

--

Img

Thermo Scientific

PIPA5122260

--

Img

Thermo Scientific

PIMA525957

--

Img

Thermo Scientific

PIPA5103552

--

Description

  • This gene encodes a homodimeric glycoprotein that hydrolyses the terminal alpha-galactosyl moieties from glycolipids and glycoproteins
  • This enzyme predominantly hydrolyzes ceramide trihexoside, and it can catalyze the hydrolysis of melibiose into galactose and glucose
  • A variety of mutations in this gene affect the synthesis, processing, and stability of this enzyme, which causes Fabry disease, a rare lysosomal storage disorder that results from a failure to catabolize alpha-D-galactosyl glycolipid moieties.